0001562180-21-004349.txt : 20210617
0001562180-21-004349.hdr.sgml : 20210617
20210617160831
ACCESSION NUMBER: 0001562180-21-004349
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: LYNCH DANIEL
CENTRAL INDEX KEY: 0001177082
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35966
FILM NUMBER: 211024786
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: bluebird bio, Inc.
CENTRAL INDEX KEY: 0001293971
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc
DATE OF NAME CHANGE: 20040616
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-06-15
false
0001293971
bluebird bio, Inc.
BLUE
0001177082
LYNCH DANIEL
C/O BLUEBIRD BIO, INC.
60 BINNEY STREET
CAMBRIDGE
MA
02142
true
false
false
false
Common Stock
2021-06-15
4
A
false
4353.00
0.00
A
12312.00
D
Stock Option (right to buy)
32.83
2021-06-15
4
A
false
7000.00
0.00
A
2031-06-15
Common Stock
7000.00
7000.00
D
These restricted stock units for common stock vest 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders.
This option vests 100% on the earlier of June 15, 2022 or the date of the next annual meeting of stockholders.
/s/ Jason F. Cole, Attorney-in-Fact
2021-06-17